Cryptogenic cirrhosis in the region where obesity is not prevalent
- PMID: 16610061
- PMCID: PMC4087689
- DOI: 10.3748/wjg.v12.i13.2080
Cryptogenic cirrhosis in the region where obesity is not prevalent
Abstract
Aim: Recent studies have demonstrated that obesity is the common feature of cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis. However, there is little information on CC in the region where obesity is not prevalent.
Methods: The clinical features, and the liver-related morbidity and mortality of CC were analyzed in Japan where the prevalence of obesity is low. Among 652 cirrhotic patients, we identified 29 patients (4.4%) with CC. Of these, 24 CC patients who were followed up for more than 6 months were compared in a case-control study with age-, sex-, and Child-Pugh score-matched controls having cirrhosis of viral etiology.
Results: Obesity (BMI>or=25 kg/m(2)), diabetes mellitus, and hypertriglyceridemia were more frequent, and the visceral fat area was larger in the CC patients than in the controls. The indices of insulin resistance were higher and the serum aminotransferase levels were lower in the CC patients than in the controls. Logistic regression analysis identified the elevated hemoglobin A1c, BMI>or=25 kg/m(2), and normal aminotransferase levels as independent predictors of CC. Kaplan-Meier analysis demonstrated lower occurrence of hepatocellular carcinoma and higher survival rate in the CC than in the controls in contrast to the similar cumulative probability of liver-related morbidity between those groups.
Conclusion: CC more frequently presents with the clinical features suggestive of non-alcoholic steatohepatitis compared with controls even in the region where obesity is not prevalent. The lower occurrence of hepatocellular carcinoma and higher survival rate may indicate an indolent clinical course in CC as compared with viral cirrhosis.
Figures


Similar articles
-
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.Gastroenterology. 2002 Jul;123(1):134-40. doi: 10.1053/gast.2002.34168. Gastroenterology. 2002. PMID: 12105842
-
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.Hepatology. 2002 Jun;35(6):1485-93. doi: 10.1053/jhep.2002.33324. Hepatology. 2002. PMID: 12029634
-
Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.J Gastroenterol Hepatol. 2011 Sep;26(9):1417-24. doi: 10.1111/j.1440-1746.2011.06775.x. J Gastroenterol Hepatol. 2011. PMID: 21884248
-
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239. J Gastroenterol Hepatol. 2013. PMID: 24251711 Review.
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594. Hepatology. 2010. PMID: 20432259 Review.
Cited by
-
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.World J Gastroenterol. 2017 Feb 28;23(8):1458-1468. doi: 10.3748/wjg.v23.i8.1458. World J Gastroenterol. 2017. PMID: 28293093 Free PMC article.
-
Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?World J Hepatol. 2022 Feb 27;14(2):354-371. doi: 10.4254/wjh.v14.i2.354. World J Hepatol. 2022. PMID: 35317172 Free PMC article. Review.
-
Liver biopsy for histological assessment: The case in favor.Saudi J Gastroenterol. 2010 Apr-Jun;16(2):133-9. doi: 10.4103/1319-3767.61245. Saudi J Gastroenterol. 2010. PMID: 20339188 Free PMC article.
-
Prevalence of Risk Factors for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Patients With Cryptogenic Cirrhosis.J Clin Exp Hepatol. 2022 Mar-Apr;12(2):492-502. doi: 10.1016/j.jceh.2021.05.008. Epub 2021 Jun 16. J Clin Exp Hepatol. 2022. PMID: 35535099 Free PMC article.
-
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2. doi: 10.1016/j.cgh.2012.10.001. Epub 2012 Oct 4. Clin Gastroenterol Hepatol. 2012. PMID: 23041539 Free PMC article.
References
-
- Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol. 1994;89:1836–1839. - PubMed
-
- Greeve M, Ferrell L, Kim M, Combs C, Roberts J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology. 1993;17:593–598. - PubMed
-
- Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol. 2002;33:1098–1104. - PubMed
-
- Uchida T, Shimojima M, Gotoh K, Shikata T, Tanaka E, Kiyosawa K. "Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol. 1994;38:281–285. - PubMed
-
- Del Gaudio A, Boschi L, Del Gaudio GA, Mastrangelo L, Munari D. Liver damage in obese patients. Obes Surg. 2002;12:802–804. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical